We Think That There Are More Issues For Blue Jet Healthcare (NSE:BLUEJET) Than Just Sluggish Earnings
Despite Blue Jet Healthcare Limited's (NSE:BLUEJET) recent earnings report having lackluster headline numbers, the market responded positively. While shareholders may be willing to overlook soft profit numbers, we believe that they should also be taking into account some other factors which may be cause for concern.
Examining Cashflow Against Blue Jet Healthcare's Earnings
In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. The ratio shows us how much a company's profit exceeds its FCF.
Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.
Over the twelve months to September 2026, Blue Jet Healthcare recorded an accrual ratio of 0.33. We can therefore deduce that its free cash flow fell well short of covering its statutory profit, suggesting we might want to think twice before putting a lot of weight on the latter. Over the last year it actually had negative free cash flow of ₹688m, in contrast to the aforementioned profit of ₹2.85b. It's worth noting that Blue Jet Healthcare generated positive FCF of ₹308m a year ago, so at least they've done it in the past. Notably, the company has issued new shares, thus diluting existing shareholders and reducing their share of future earnings.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. As it happens, Blue Jet Healthcare issued 9.1% more new shares over the last year. As a result, its net income is now split between a greater number of shares. Per share metrics like EPS help us understand how much actual shareholders are benefitting from the company's profits, while the net income level gives us a better view of the company's absolute size. Check out Blue Jet Healthcare's historical EPS growth by clicking on this link.
A Look At The Impact Of Blue Jet Healthcare's Dilution On Its Earnings Per Share (EPS)
As you can see above, Blue Jet Healthcare has been growing its net income over the last few years, with an annualized gain of 58% over three years. Net profit actually dropped by 19% in the last year. Unfortunately for shareholders, though, the earnings per share result was even worse, declining 21%. So you can see that the dilution has had a bit of an impact on shareholders.
In the long term, if Blue Jet Healthcare's earnings per share can increase, then the share price should too. However, if its profit increases while its earnings per share stay flat (or even fall) then shareholders might not see much benefit. For that reason, you could say that EPS is more important that net income in the long run, assuming the goal is to assess whether a company's share price might grow.
Our Take On Blue Jet Healthcare's Profit Performance
As it turns out, Blue Jet Healthcare couldn't match its profit with cashflow and its dilution means that shareholders own less of the company than the did before (unless they bought more shares). Considering all this we'd argue Blue Jet Healthcare's profits probably give an overly generous impression of its sustainable level of profitability. If you'd like to know more about Blue Jet Healthcare as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 1 warning sign for Blue Jet Healthcare you should know about.
In this article we've looked at a number of factors that can impair the utility of profit numbers, and we've come away cautious. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.